Year
2016
Status
Active
Team
Field
Immuno-oncology therapeutic
Location
München (Germany)
Fund
BGV III
Catalym
Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
2016
Active
Immuno-oncology therapeutic
München (Germany)
BGV III
Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.